Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 2
1998 3
1999 1
2000 3
2002 2
2003 1
2004 1
2005 1
2006 2
2007 6
2008 5
2009 2
2010 5
2011 4
2012 4
2013 2
2014 6
2015 4
2016 2
2017 3
2018 3
2019 5
2020 3
2021 3
2022 3
2023 5
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial.
Noaiseh G, Sivils KL, Campbell K, Idokogi J, Lo KH, Liva SG, Leu JH, Dhatt H, Ma K, Leonardo S, Li H, Hubbard JJ, Gottenberg JE. Noaiseh G, et al. Among authors: leu jh. Lancet. 2025 Nov 22;406(10518):2435-2448. doi: 10.1016/S0140-6736(25)01430-8. Epub 2025 Oct 24. Lancet. 2025. PMID: 41284548 Free article. Clinical Trial.
Nipocalimab Dose Selection in Generalized Myasthenia Gravis.
Valenzuela B, Neyens M, Zhu Y, Ramchandren S, Dosne AG, Leu JH, Faelens R, Ling LE, Pérez-Ruixo JJ. Valenzuela B, et al. Among authors: leu jh. CPT Pharmacometrics Syst Pharmacol. 2025 Sep 17. doi: 10.1002/psp4.70109. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2025. PMID: 40960093 Free article.
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Alexeeva E, Appenzeller S, Chasnyk V, Griffin T, Suarez CN, Knupp-Oliveira S, Zeft A, Aviel YB, De Ranieri D, Gottlieb BS, Levy DM, Rabinovich CE, Silva CA, Spivakovsky Y, Uziel Y, Ringold S, Xu XL, Leu JH, Lam E, Wang Y, Lovell DJ, Martini A, Ruperto N; Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO). Brunner HI, et al. Among authors: leu jh. J Rheumatol. 2025 Oct 1;52(10):1069. doi: 10.3899/jrheum.2024-0298.C1. J Rheumatol. 2025. PMID: 40763950 No abstract available.
IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk Assessment.
Grimaldi C, Richards S, Baltrukonis D, Sims Belouski S, Coble K, Dholakiya SL, Grudzinska-Goebel J, Kolaitis G, Leu JH, Luo L, Lowe S, Niu T, Toft-Hansen H, Yang J, Wu B. Grimaldi C, et al. Among authors: leu jh. Clin Pharmacol Ther. 2025 Jun;117(6):1596-1604. doi: 10.1002/cpt.3568. Epub 2025 Jan 28. Clin Pharmacol Ther. 2025. PMID: 39876095 Free PMC article. Review.
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.
Komatsu Y, Verweij EJTJ, Tiblad E, Lopriore E, Oepkes D, Agarwal P, Lam E, Leu JH, Ling LE, Nelson RM, Olusajo V, Saeed-Khawaja S, Tjoa ML, Zhou J, Amin U, Sirah W, Moise KJ. Komatsu Y, et al. Among authors: leu jh. Am J Perinatol. 2025 May;42(7):842-853. doi: 10.1055/a-2404-8089. Epub 2024 Aug 28. Am J Perinatol. 2025. PMID: 39197469 Free PMC article.
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. Among authors: leu jh. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
83 results